心脏磁共振延迟钆增强对肥厚型心肌病患者非持续性室性心动过速及心源性猝死的预后价值:一项Meta分析
该Meta分析纳入20项研究,评估心脏磁共振延迟钆增强预测肥厚型心肌病患者非持续性室性心动过速和心源性猝死的价值。延迟钆增强预测非持续性室性心动过速的汇总敏感度为91.33%、特异度37.45%、准确度52.86%;其存在与心源性猝死显著相关(OR 3.64),非持续性室性心动过速患者延迟钆增强范围更大。
要点
- 延迟钆增强预测非持续性室性心动过速敏感度高(91.33%)但特异度低(37.45%)。
- 延迟钆增强存在与心源性猝死显著相关(OR 3.64,95%CI 2.36-5.61)。
- 非持续性室性心动过速患者延迟钆增强范围较无者高5.95%(WMD)。
核心结论
- 心脏磁共振延迟钆增强预测非持续性室性心动过速敏感度高但特异度和准确度有限,其存在与心源性猝死显著相关,非持续性室性心动过速患者延迟钆增强范围更大。
研究设计与样本
- Meta分析,纳入20项评估延迟钆增强对肥厚型心肌病患者非持续性室性心动过速和心源性猝死预后价值的研究,采用随机效应模型汇总敏感度、特异度、准确度、预测值和似然比。
关键影像表现/征象
- 非持续性室性心动过速患者延迟钆增强范围较无者高5.95%(95%CI 3.08-8.81,p<0.0001)。
- 非持续性室性心动过速患病率为28.73%(95%CI 20.91-36.54)。
诊断标准与关键数值
- 延迟钆增强预测非持续性室性心动过速的汇总敏感度91.33%(95%CI 88.81-93.86)、特异度37.45%(95%CI 31.60-43.31)、准确度52.86%(95%CI 45.73-59.98)。
- 阳性似然比1.40,阴性似然比0.23,阳性预测值36.35%,阴性预测值92.03%。
- 延迟钆增强存在与心源性猝死相关(OR 3.64,95%CI 2.36-5.61,p<0.00001)。
临床应用与阅片要点
- 延迟钆增强可用于非持续性室性心动过速的风险预测,但单独应用特异度和准确度有限。
- 预测值和似然比存在变异,作者认为需将延迟钆增强与其他影像生物标志物结合以改善风险分层。
局限性
- 预测值和似然比的变异性提示需将延迟钆增强与其他影像生物标志物结合。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Non-sustained ventricular tachycardia (NSVT) is an independent predictor of sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM). This meta-analysis evaluates the prognostic value of late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) for predicting NSVT and its association with SCD in HCM.
MATERIALS AND METHODS: We screened electronic databases for studies evaluating the prognostic value of LGE in predicting NSVT and SCD in HCM patients. A random-effects model estimated pooled sensitivity, specificity, accuracy, predictive values, and likelihood ratios for NSVT prediction. Association between LGE extent and NSVT incidence was analyzed using weighted mean differences (WMDs), while pooled odds ratios (ORs) with 95% CIs were calculated to assess LGE's association with SCD.
RESULTS: Among 20 studies, LGE showed a pooled sensitivity, specificity, and accuracy of 91.33% (95% CI: 88.81-93.86), 37.45% (95% CI: 31.60-43.31), and 52.86% (95% CI: 45.73-59.98), respectively, for NSVT prediction. Positive and negative likelihood ratios and predictive values were, 1.40 and 0.23, and 36.35% and 92.03%, respectively. Patients with NSVT had a significantly greater LGE extent than those without (WMD: 5.95%, 95% CI: 3.08-8.81, p < 0.0001). NSVT prevalence was 28.73% (95% CI: 20.91-36.54). Additionally, LGE presence and SCD were significantly associated (OR 3.64, 95% CI: 2.36-5.61, p < 0.00001).
CONCLUSION: LGE on CMR shows high sensitivity but limited specificity and accuracy for NSVT prediction. Moreover, LGE presence was significantly associated with SCD, and NSVT patients had greater LGE extent. Nonetheless, variability in predictive values and likelihood ratios underscores the need to combine LGE with other imaging biomarkers.
KEY POINTS: Question Can LGE on CMR predict NSVT and SCD in HCM patients? Findings LGE demonstrated high sensitivity but limited specificity for NSVT prediction. Moreover, LGE presence was significantly associated with SCD, and NSVT patients had greater LGE extent. Clinical relevance LGE on CMR is a valuable marker for NSVT prediction and SCD in HCM patients, but it is not widely integrated into clinical practice. Our study highlights the need to integrate LGE with other imaging biomarkers for improved risk stratification.
引用
- Siddiqi AK, Maniya MT, Bilen O, et al. Prognostic value of late gadolinium enhancement on cardiac magnetic resonance imaging for non-sustained ventricular tachycardia and sudden cardiac death in hypertrophic cardiomyopathy: a meta-analysis. Eur Radiol. 2025. PMID: 40836019. doi:10.1007/s00330-025-11961-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。